About Malik Lifesciences Private Limited
Data last updated:
Malik Lifesciences Private Limited is a private limited company based in Delhi, India, a subsidiary of Akums Drugs And Pharmaceuticals Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 February 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U63021DL2004PTC299408. Its GSTIN is 07AAECM9025E1ZL (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹46.7 Lakh. It was formerly known as Malik Fragrances Private Limited and Ambience Storage Solutions (India) Private Limited. It is led by directors including Samandar Singh Dhakad (Whole-Time Director) and Vijaypal Singh Rawat (Whole-Time Director).
Its last annual general meeting (AGM) was held on 14 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 301 Third Floor Mohan Place Lsc Block – C, Saraswati Vihar, Delhi, India – 110034.
As per the financials filed for FY 2026, the company reported a revenue of ₹623.38 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹28.41 Cr (net margin 4.6%) and EBITDA of ₹64.47 Cr (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 18% over five years.
The company has about 359 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Akums. As per MCA filings, the company has open charges of ₹126 Cr and satisfied charges of ₹15 Cr on record. Court records list 37 cases involving the company, including 30 filed by the company and 7 filed against it; 19 cases are pending. The company has 4 deals on record (2 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹45.2 Lakh; the latest was in June 2019.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website akums.in.
Company details
Name history
Malik Lifesciences has undergone 2 name changes throughout its history. The company was previously known as Malik Fragrances Private Limited, and Ambience Storage Solutions (India) Private Limited. The current legal name is Malik Lifesciences Private Limited.
| Company Name | Status |
|---|---|
| Malik Lifesciences Private Limited | Current |
| Malik Fragrances Private Limited | Previous |
| Ambience Storage Solutions (India) Private Limited | Previous |
CIN history
Malik Lifesciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U63021DL2004PTC299408, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U63021DL2004PTC299408 | Current |
| U63021UP2004PTC028270 | Previous |
| U63021UR2004PTC028270 | Previous |
Contact details
Malik Lifesciences Private Limited's registered office is in Delhi, Delhi. Its website is akums.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address301 Third Floor Mohan Place Lsc Block – C, Saraswati Vihar, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Malik Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Malik Lifesciences is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Malik Lifesciences Private Limited, buy the company report.
Financials of Malik Lifesciences Private Limited
FY 2026 filings availableMalik Lifesciences Private Limited reported revenue of ₹623.38 Cr (up 5% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 5% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹623.38 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹64.47 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28.41 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.3% | ||||
| Net Profit Margin | 4.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Malik Lifesciences Private Limited, buy the company report.
Board of directors of Malik Lifesciences Private Limited
Malik Lifesciences has 4 current directors and 23 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samandar Singh Dhakad Also directs: Akome Lifecare Private Limited, Akums Healthcare Limited | Whole-Time Director | 29 Sep 2014 | 12 Years 1 Months | Current |
| Suman | Director | 22 Jul 2015 | 11 Years 3 Months | Current |
| Vijaypal Singh Rawat | Whole-Time Director | 13 Aug 2020 | 6 Years 2 Months | Current |
| Devendra Singh | Director | 07 Aug 2026 | 0 Years 3 Months | Current |
Auditor
Malik Lifesciences Private Limited is audited by WALKER CHANDIOK & CO. LLP for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| WALKER CHANDIOK & CO. LLP | FY 2026 | 001076N/N500013 |
Shareholding
The shareholding of Malik Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Malik Lifesciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Apr 2024 | 100907091 | The Hongkong and Shanghai Banking Corporation Limited | ₹25 Cr | Open | |
| 23 Sep 2021 | 100484412 | Citi Bank N.A. | ₹20 Cr | Open | |
| 02 Jul 2016 | 100041207 | Hdfc Bank Limited | ₹49 Cr | Open | |
| 29 Mar 2014 | 10488135 | Yes Bank Limited | ₹32 Cr | Open | |
| 04 Apr 2022 | 100567307 | Standard Chartered Bank | ₹15 Cr | Satisfied |
To see the full charge records of Malik Lifesciences Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Malik Lifesciences Private Limited has 4 deals on record (2 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹45.2 Lakh; the latest was in June 2019.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2019 | Secondary share transfer | Undisclosed | Buyer: Akums Drugs and Pharmaceuticals Limited Seller: 2 individuals |
| May 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Akums Drugs and Pharmaceuticals Limited |
| Jun 2013 | Acquisition | ₹1.68 Cr | Buyer: Akums Drugs and Pharmaceuticals Limited Seller: 4 individuals |
| Mar 2010 | Funding round | ₹45.2 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Malik Lifesciences Private Limited has 37 court cases on record: 30 filed by Malik Lifesciences, 7 filed against it. 19 cases are pending and 18 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 32 | 4 | 15 |
| High courts | 5 | 3 | 4 |
Cases on record (5 of 37)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| District court, South East, Delhi | Cheque dishonour complaint | Filed by the company against Allites Life Sciences Private Limited and 2 others | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Scutonix Lifesciences Pvt. Ltd. | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Laxo Medicare Pvt Ltd | Pending |
To see the full case history of Malik Lifesciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Malik Lifesciences Private Limited was last rated by Icra on 09 Jun 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 09 Jun 2021 |
To see the full credit ratings and regulatory alerts of Malik Lifesciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Malik Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Malik Lifesciences Private Limited has a workforce of 359 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
GST
Malik Lifesciences has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECM9025E1ZL | Delhi | Active | 11 Jul 2017 |
| 05AAECM9025E1ZP | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Malik Lifesciences Private Limited, buy the company report.
Recent activity
Malik Lifesciences Private Limited has 27 board changes on record since 2013: 4 appointments and 23 cessations. The latest: Devendra Singh was appointed as Director on 07 Aug 2026.
26 earlier events are in the company report.
News
Frequently asked questions
Malik Lifesciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 February 2004 (22+ years old) and is registered under CIN U63021DL2004PTC299408.
Malik Lifesciences has 4 current directors:
- Samandar Singh Dhakad - Whole-Time Director
- Vijaypal Singh Rawat - Whole-Time Director
- Suman - Director
- Devendra Singh - Director
The latest financial statements of Malik Lifesciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 14 June 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Malik Lifesciences is 07AAECM9025E1ZL, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 05AAECM9025E1ZP (Uttarakhand).
The CIN (Corporate Identification Number) of Malik Lifesciences is U63021DL2004PTC299408. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Malik Lifesciences has 37 court cases on record: 30 filed by the company and 7 filed against it. 19 are pending. Most are in the district courts.
Malik Lifesciences was incorporated on 05 February 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Malik Lifesciences has 4 deals on record (2 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹45.2 Lakh; the latest was in June 2019.
Devendra Singh was appointed as Director on 07 Aug 2026. Manmohan Singh ceased to be Additional Director on 28 May 2024. Rohitaswa ceased to be Whole-Time Director on 22 Mar 2021. Malik Lifesciences has 27 board changes on record in total.
Malik Lifesciences can be reached through the website akums.in. Its registered office is in Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
